“Structure-Based Molecular Docking Study of a Designed Cationic Peptide Sequence KRLVAGLIRKLA Against Targeting the Extracellular Domain of HER2 in HER2-Positive Breast Cancer” (2026) Annual Methodological Archive Research Review, 4(3), pp. 985–1101. doi:10.66021/.